DENVER — Pritelivir, an investigational antiviral drug for herpes simplex virus, demonstrated “superior efficacy” in healing ...

Epidemiological studies suggest that HSV-2 increases the risk of HIV-1 acquisition. 1, 2, 3 In populations with HSV-2 prevalence of 80%, nearly 50% of HIV-1 infections are attributable to an HSV-2 ...

In a subgroup analysis of people living with HIV enrolled in PRIOH-1, pritelivir demonstrated superior lesion healing, achieving 61% complete ...

为解决现有抗 HSV-2 药物疗效有限及耐药问题，研究人员开展新型螺环硫代嘧啶酮化合物抗 HSV-2 研究。结果显示，化合物 3 抗病毒活性良好，能抑制病毒吸附、复制，调节凋亡通路。这为开发新的抗 HSV-2 疗法提供了方向。 在全球范围内，病毒感染对人类健康构成 ...

为了解美国 HSV-2 型生殖器疱疹（GH）患者的真实生活体验及评估现有患者报告结局（PRO）措施的适用性，研究人员开展了结构化文献回顾和概念引出访谈研究。结果发现患者有多种症状和生活质量影响，现有 PRO 措施能综合覆盖相关概念，有助于改善患者护理。

WOBURN, Mass. and OXFORD, England, July 8, 2022 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced ...

Figure 1: Persistence and localization of CD4 + and CD8 + T cells in genital lesions of immunocompetent subjects. Figure 2: Persistence of CD4 + and CD8 + T cells in genital skin of subjects on daily ...

Herpes simplex virus 2 (HSV-2) is a sexually transmitted infection that can cause painful, recurrent lesions in the genital skin and mucosa. HSV-2 initially infects genital epithelial cells before ...

Herpes simplex virus 1 (HSV-1) and virus 2 (HSV-2), better known clinically as Human alphaherpesvirus 1 and Human alphaherpesvirus 2, are members of the human Herpesviridae family. This is a set of ...

COBAS ANALYZER for use with Elecsys HSV-1 IgG and HSV-2 IgG Assays by Roche Roche announced that it has received clearance from the FDA for its IgG Antibody to herpes simplex virus (HSV) types 1 and 2 ...

System from Quest Diagnostics’ products business is first FDA-cleared Herpes Simplex Virus 1 and 2 test that uses genital swab or cerebrospinal fluid (CSF) specimen collection Quest Diagnostics (NYSE: ...